Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inmed Pharmaceuticals Inc (NQ: INM ) 0.3033 -0.0117 (-3.71%) Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 666,286 Open 0.3120 Bid (Size) 0.3003 (1) Ask (Size) 0.3106 (9) Prev. Close 0.3150 Today's Range 0.2902 - 0.3197 52wk Range 0.2275 - 2.080 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News INM Stock Earnings: InMed Pharmaceuticals Reported Results for Q3 2024 May 14, 2024 InMed Pharmaceuticals just reported results for the third quarter of 2024. Via InvestorPlace CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial Results, Business Update May 14, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Performance YTD -22.23% -22.23% 1 Month +0.10% +0.10% 3 Month -25.42% -25.42% 6 Month -21.22% -21.22% 1 Year -76.12% -76.12% More News Read More InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic Abilities May 07, 2024 Via News Direct Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket May 01, 2024 Via Benzinga Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket April 24, 2024 Via Benzinga CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in Alzheimer’s Research to Scientific Advisory Board April 18, 2024 Via Investor Brand Network CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD April 16, 2024 Via Investor Brand Network InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results from INM-901 Preclinical AD Studies April 04, 2024 Via Investor Brand Network TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extension March 21, 2024 Via Investor Brand Network InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying February 23, 2024 Via Benzinga Topics Stocks Exposures US Equities Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying February 22, 2024 Via Benzinga Topics Stocks Exposures US Equities BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Numbers for Q2 2024, Corporate Update February 14, 2024 Via Investor Brand Network BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer February 09, 2024 Via Investor Brand Network InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need January 26, 2024 Via News Direct InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need January 25, 2024 Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at January Water Tower Research Fireside Chat January 19, 2024 Via Investor Brand Network CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones January 16, 2024 Via Investor Brand Network CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones January 16, 2024 Via CannabisNewsWire Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket December 21, 2023 Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Approves Election of Directors During 2023 Annual General Meeting December 20, 2023 Via Investor Brand Network Investment Chief At $48B Global X Forecasts AI Stock Dominance In 2024: Unveils Top Investment Opportunities December 17, 2023 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence InMed’s (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer’s with a Rare Cannabinoid Analog December 12, 2023 Via News Direct Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday December 12, 2023 Via InvestorPlace InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog December 11, 2023 Via Benzinga InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Advancing INM-089 to Target Treatment of Age-Related Macular Degeneration November 29, 2023 Via Investor Brand Network Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
